Results 141 to 150 of about 21,600 (215)

miR-184 modulates Ilp8 to control developmental timing during normal growth conditions and in response to developmental perturbations. [PDF]

Development
Fernandes J, Naseem M, Mangattu Parambil AM, Varghese J.   +3 more
europepmc   +1 more source

Ricin Immunoconjugate [PDF]

, 2020
openaire   +1 more source

Binding of small molecules at the P-stalk site of ricin A subunit trigger conformational changes that extend into the active site. [PDF]

J Biol Chem
McLaughlin JE, Rudolph MJ, Dutta A, Li XP, Tsymbal AM, Chen Y, Bhattacharya S, Algava B, Goger M, Roberge JY, Tumer NE.   +10 more
europepmc   +1 more source

Design and Characterization of Ricin Based Immunotoxins Against EPHA2 Receptor for Breast Cancer Therapy: An In-Silico Study. [PDF]

Iran J Pharm Res
Faraz A, Amani J, Arbabian S, Zare Karizi S, Bikhof Torbati M.   +4 more
europepmc   +1 more source

Expression and characterization of an endo-β-1,6-galactanase from Arabidopsis thaliana. [PDF]

Biochem J
Gistelinck K, Yu X, Leyder A, Osterne VJS, Desmet T, Tryfona T, Van Damme EJM.   +6 more
europepmc   +1 more source

<i>N</i>-Glycosylation Profile of Abrin Certified EU Reference Material. [PDF]

Toxins (Basel)
Josuran R, Wenger A, Worbs S, Kampa B, Rummel A, Dorner BG, Gerber S.   +6 more
europepmc   +1 more source

Primary Sequence and Three-Dimensional Structural Comparison between Malanin and Ricin, a Type II Ribosome-Inactivating Protein. [PDF]

Toxins (Basel)
Yuan Y, Wu S, Day PJR.
europepmc   +1 more source

Development of Effective Medical Countermeasures Against the Main Biowarfare Agents: The Importance of Antibodies. [PDF]

Microorganisms
Avril A, Guillier S, Rasetti-Escargueil C.   +2 more
europepmc   +1 more source

Toxicity and Efficacy Evaluation of Soluble Recombinant Ricin Vaccine. [PDF]

Vaccines (Basel)
Yun H, Joe HE, Song DH, Song YJ, Hong S, Kim CH, Kim NY, Hur GH, Yu CH.   +8 more
europepmc   +1 more source